$1.72
0.148.86%
At Close: -
$1.67
-0.05-2.84%
After Hours: 4:43 PM EDT
15 minutes delayed
Comments
Loading...
Coherus BioSciences (NASDAQ:CHRS) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/10/2024 | CHRS | Coherus BioSciences | Q4 | 2023 | — | — | — | $90.00M | — | $95.68M | Get Alert |
| 01/10/2024 | CHRS | Coherus BioSciences | FY | 2023 | — | — | — | $260.00M | $260.00M | $260.53M | Get Alert |
| 11/06/2023 | CHRS | Coherus BioSciences | FY | 2023 | — | — | — | $250.00M | $260.00M | $288.19M | Get Alert |
| 08/02/2023 | CHRS | Coherus BioSciences | FY | 2023 | — | — | — | $275.00M | — | $266.16M | Get Alert |
| 05/08/2023 | CHRS | Coherus BioSciences | FY | 2023 | — | — | — | $275.00M | — | $344.75M | Get Alert |
| 04/13/2020 | CHRS | Coherus BioSciences | Q1 | 2020 | — | — | — | $115.00M | $117.50M | $118.85M | Get Alert |
FAQ
What is the most recent guidance for Coherus BioSciences (CHRS)?
There have been no specific sales or earnings guidance reported for Coherus BioSciences in recent months.
Browse guidance and forecast on all stocks.